Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guidant issues second consecutive performance warning

This article was originally published in Clinica

Executive Summary

Guidant has warned that its fourth-quarter revenues will be below analysts' estimates and that its earnings per share will be down by between two and three cents as a result. Analysts were expecting earnings of 43 cents a share, compared with 36 cents a year ago. The announcement follows a similar warning by the company in October for its third-quarter sales (see Clinica No 929, p 13).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT069512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel